K Pharma,Inc. Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	-	1,000	-	-
Cost of Revenue	-	-	90	-	-
Gross Profit	-	-	910	-	-
Selling, General & Admin	428	380	259	353	219
Research & Development	451	451	255	-	-
Other Operating Expenses	5	5	29	-	-
Operating Expenses	884	836	543	353	219
Operating Income	-884	-836	367	-353	-219
Currency Exchange Gain (Loss)	-1	-1	-	-	-
Other Non Operating Income (Expenses)	-	-	-24	-7	-1
EBT Excluding Unusual Items	-882	-837	343	-360	-220
Gain (Loss) on Sale of Assets	-	-	-	-31	-8
Asset Writedown	-18	-7	-43	-	-
Pretax Income	-900	-844	300	-391	-228
Income Tax Expense	3	2	40	1	-
Net Income	-903	-846	260	-392	-228
Net Income to Common	-903	-846	260	-392	-228
Shares Outstanding (Basic)	12	12	10	9	8
Shares Outstanding (Diluted)	12	12	11	9	8
Shares Change (YoY)	0.62%	2.97%	20.79%	22.75%	-
EPS (Basic)	-77.81	-72.90	25.39	-42.01	-30.00
EPS (Diluted)	-77.81	-72.90	23.07	-42.01	-30.00
Free Cash Flow	-	-997	445	-	-
Free Cash Flow Per Share	-	-85.91	39.48	-	-
Gross Margin	-	-	91.00%	-	-
Operating Margin	-	-	36.70%	-	-
Profit Margin	-	-	26.00%	-	-
Free Cash Flow Margin	-	-	44.50%	-	-
EBIT	-884	-836	367	-353	-219
EBIT Margin	-	-	36.70%	-	-
Effective Tax Rate	-	-	13.33%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.